I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony histologicznie nowotwór piersi
- •Guz w piersi o wymiarze co najmniej 2,5 cm, widoczny w badaniach obrazowych
- •Wiek co najmniej 18 lat
- •Dobry stan ogólny (skala ECOG 0-1)
- •Chęć poddania się biopsji guza celem zbadania jego właściwości
- •Brak wcześniejszej chemioterapii lub radioterapii piersi
- •Niezawierająca metal implanty metalowe niezgodne z rezonansem magnetycznym
- •Prawidłowe wyniki badań krwi i organów wewnętrznych
✗ Disqualifies
- •Zastosowanie innych badań eksperymentalnych w ciągu ostatnich 30 dni
- •Uczulenie na substancje chemiczne podobne do leku badanego
- •Niekontrolowana choroba serca, aktywna infekcja lub poważne problemy psychiatryczne
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- May 6, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (42)
University of Alabama at Birmingham
Birmingham, United States
Mayo Clinic - Scottsdale
Scottsdale, United States
University of Arizona
Tucson, United States
University of California - Davis, Comprehensive Cancer Center
Davis, United States
City of Hope
Duarte, United States
University of California San Diego
La Jolla, United States
University of Southern California
Los Angeles, United States
HOAG Memorial Hospital Presbyterian
Newport Beach, United States
University of California San Francisco (UCSF)
San Francisco, United States
University of Colorado Cancer Center
Aurora, United States
Yale Cancer Center
New Haven, United States
Georgetown University Medical Center
Washington D.C., United States
H. Lee Moffitt Cancer Center and Research Institute
Tampa, United States
Moffitt Cancer Center
Tampa, United States
Winship Cancer Institute of Emory University
Atlanta, United States
University of Chicago
Chicago, United States
Loyola University
Maywood, United States
University of Kansas
Westwood, United States
Herbert-Herman Cancer Center, Sparrow Hospital
Lansing, United States
University of Minnesota
Minneapolis, United States
Mayo Clinic
Rochester, United States
Metro Minnesota Community Oncology Research Consortium, Hennepin County Medical Center
Saint Louis Park, United States
Rutgers Cancer Institute of New Jersey
New Brunswick, United States
Roswell Park Cancer Institute
Buffalo, United States
Laura and Isaac Perlmutter Cancer Center / NYU Langone Health
New York, United States
Columbia University Medical Center
New York, United States
University of Rochester Wilmot Cancer Institute
Rochester, United States
Montefiore Medical Center
The Bronx, United States
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, United States
Cleveland Clinic
Cleveland, United States
The Ohio State University, Stefanie Spielman Comprehensive Breast Center
Columbus, United States
Oregon Health & Science Institute (OHSU)
Portland, United States
University of Pennsylvania (U Penn)
Philadelphia, United States
University Pittsburgh Medical Center
Pittsburgh, United States
Sanford Clinical Research
Sioux Falls, United States
Vanderbilt University Medical Center
Nashville, United States
University of Texas, Southwestern Medical Center
Dallas, United States
University of Texas, M.D. Anderson Cancer Center
Houston, United States
Huntsman Cancer Institute, University of Utah
Salt Lake City, United States
Inova Health System
Falls Church, United States
Swedish Cancer Institute
Seattle, United States
University of Washington
Seattle, United States
Trial contact
Heather Prisant
Contact information from ClinicalTrials.gov. Contact in English.
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.